» Articles » PMID: 8708681

Incidence of Intracranial Tumours in the Lothian Region of Scotland, 1989-90

Overview
Date 1996 Aug 1
PMID 8708681
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the incidence of primary and secondary intracranial tumours in the Lothian region of south east Scotland.

Methods: A population based study was performed. Patients from Lothian with incident intracranial tumours diagnosed in 1989 and 1990 (by CT or histology) were identified retrospectively using multiple sources. Differences in incidence by tumour type, age, sex, and socioeconomic status were examined.

Results: Four hundred and forty two patients with incident intracranial tumours were identified (228 primary tumours and 214 secondary tumours). The crude yearly incidences of primary and secondary tumours were 15.3 and 14.3 per 100,000 respectively. The commonest primary tumours were neuroepithelial tumours (53.5%), meningeal tumours (19.5%), and sellar tumours (16.5%). About 50% of patients with secondary tumours had an underlying lung cancer. The incidence of primary and secondary tumours increased markedly with age. Meningeal tumours were more common in women, and neuroepithelial tumours were more common in those who lived in more affluent areas.

Conclusions: The incidence rates of primary and secondary intracranial tumours in Lothian were more than twice those previously reported in the United Kingdom. Intracranial tumours are a significant cause of morbidity and mortality in the United Kingdom, and further research into their aetiology and treatment is urgently required.

Citing Articles

Invasion and metastasis in cancer: molecular insights and therapeutic targets.

Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X Signal Transduct Target Ther. 2025; 10(1):57.

PMID: 39979279 PMC: 11842613. DOI: 10.1038/s41392-025-02148-4.


Hippocampal avoidance whole brain radiotherapy in brain metastasis using volumetric modulated arc therapy: experience from a Regional Cancer Centre of Eastern India.

Deepsikha G, Maji T, Lahiri D, Roy S, Bhanja S, Rangineni S Rep Pract Oncol Radiother. 2023; 28(4):468-477.

PMID: 37795235 PMC: 10547418. DOI: 10.5603/RPOR.a2023.0048.


Single-center study on clinicopathological and typical molecular pathologic features of metastatic brain tumor.

Kim S, Lee Y, Lee S, Sung Y, Lee A, Kang J J Pathol Transl Med. 2023; 57(4):217-231.

PMID: 37460396 PMC: 10369139. DOI: 10.4132/jptm.2023.06.10.


The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis.

Salari N, Ghasemi H, Fatahian R, Mansouri K, Dokaneheifard S, Shiri M Eur J Med Res. 2023; 28(1):39.

PMID: 36670466 PMC: 9854075. DOI: 10.1186/s40001-023-01011-y.


Epidemiologic Study of Primary Brain Tumors in Miyazaki Prefecture: A Regional 10-year Survey in Southern Japan.

Matsumoto F, Takeshima H, Yamashita S, Yokogami K, Watanabe T, Ohta H Neurol Med Chir (Tokyo). 2021; 61(8):492-498.

PMID: 34148943 PMC: 8365235. DOI: 10.2176/nmc.oa.2020-0438.


References
1.
Brewis M, POSKANZER D, Rolland C, Miller H . Neurological disease in an English city. Acta Neurol Scand. 1966; 42:Suppl 24:1-89. View

2.
Grant R, Collie D, Counsell C . The incidence of cerebral glioma in the working population: a forgotten cancer?. Br J Cancer. 1996; 73(2):252-4. PMC: 2074322. DOI: 10.1038/bjc.1996.44. View

3.
Schoenberg B, CHRISTINE B, Whisnant J . The resolution of discrepancies in the reported incidence of primary brain tumors. Neurology. 1978; 28(8):817-23. DOI: 10.1212/wnl.28.8.817. View

4.
Burgess R, Burgess V, DiBella N . Brain metastases in small cell carcinoma of the lung. JAMA. 1979; 242(19):2084-6. View

5.
Annegers J, Schoenberg B, Okazaki H, Kurland L . Epidemiologic study of primary intracranial neoplasms. Arch Neurol. 1981; 38(4):217-9. DOI: 10.1001/archneur.1981.00510040043006. View